We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Biomolecule Detection Technology to Make Lab-on-a-Chip Devices Smaller, Faster

By LabMedica International staff writers
Posted on 20 Jul 2022
Print article
Image: World’s thinnest material used for same-time, same-position biomolecule isolation and sensing (Photo courtesy of Pexels)
Image: World’s thinnest material used for same-time, same-position biomolecule isolation and sensing (Photo courtesy of Pexels)

New research has overcome a major challenge to isolating and detecting molecules at the same time and at the same location in a microdevice. The work by scientists at the University of Massachusetts Amherst (Amherst, MA, USA) demonstrates an important advance in using graphene for electrokinetic biosample processing and analysis and could allow lab-on-a-chip devices to become smaller and achieve results faster.

“For the detection of biomolecules, we usually first have to isolate them in a complex medium in a device and then send them to another device or another spot in the same device for detection,” said Jinglei Ping, an assistant professor at the Mechanical and Industrial Engineering Department, who is also affiliated with the Institute of Applied Life Sciences. “Now we can isolate them and detect them at the same microscale spot in a microfluidic device at the same time.

“No one has ever demonstrated this before,” he continued. “This is owing to our use of graphene, a nanomaterial as thin as a single carbon atom, as microelectrodes in a microfluidic device. We found that, compared to typical inert-metal microelectrodes, the electrolysis stability for graphene microelectrodes is more than 1,000 times improved, making them ideal for high-performance electrokinetic analysis.”

Also, Ping added, since monolayer graphene is transparent, “we developed a three-dimensional multi-stream microfluidic strategy to microscopically detect the isolated molecules and calibrate the detection at the same time from a direction normal to the graphene microelectrodes.”

The new approach developed in the work paves the way to the creation of lab-on-a-chip devices of maximal time and size efficiencies, Ping said. Also, the approach is not limited to analyzing biomolecules and can potentially be used to separate, detect and stimulate microorganisms such as cells and bacteria.

Related Links:
University of Massachusetts Amherst 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Ultrasonic Cleaner
UC 300 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more